| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,492 |
2025 royalty income A$65m, profit after tax A$30m
|
27 Feb 2026 9:59AM |
$13.440 |
$11.780 |
fallen by
12.35%
|
|
NEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Neuren reported A$65 million royalty income in 2025, up 15% from 2024.
- Profit after tax for 2025 was A$30 million.
- Cumulative income of A$510 million from DAYBUE® since 2023 launch.
- DAYBUE® 2025 net sales were US$391 million.
- NNZ-2591 clinical trials underway for Phelan-McDermid syndrome.
- A$296 million in cash and short-term investments at year-end 2025.
- Completed A$50 million share buy-back in 2025; new program begins March 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$20 |
Half Year Results
|
27 Feb 2026 9:58AM |
$0.047 |
$0.041 |
fallen by
12.77%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 53% to AUD 8 million.
- Net profit after tax of AUD 1.5 million achieved.
- Strong performance across Clinical Trial Management, Clinical Trial Site Services, and SaMD Image Analysis Services.
- Completion of major-pharma clinical trial services agreements.
- Expanded TrialsWest clinical site network with strong profitability.
- Substantial pipeline in Software-as-a-Medical Device services.
- Development progress on non-invasive MRI Liver Fibrosis project.
- Introduction of 'Bridge' automation technology.
- Positive outlook with expected full-year revenue of AUD 17 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marimaca Copper Corp. (MC2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$410 |
Cleansing Notice
|
27 Feb 2026 9:58AM |
$10.450 |
$8.300 |
fallen by
20.57%
|
|
| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$643 |
Share Purchase Plan - Offer Booklet
|
27 Feb 2026 9:58AM |
$0.875 |
$0.665 |
fallen by
24%
|
|
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$6 |
Appendix 4D and Interim Financial Report
|
27 Feb 2026 9:57AM |
$0.008 |
$0.007 |
fallen by
12.50%
|
|
ID8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Identitii Limited reported a comprehensive loss of AUD 2,208,361 for the half-year ended 31 December 2025.
- The company's revenue from ordinary activities increased by 8% to AUD 426,572 compared to the previous year.
- No dividends were declared for the interim period ending 31 December 2025.
- Net tangible assets decreased significantly from AUD 3,210,597 to AUD 153,357.
- The company issued 45,000,000 shares to settle a loan partially during the period.
- Research and development expenses remained significant at AUD 967,720.
- The company operates primarily in the RegTech industry, focusing on software that aids in financial crime reporting compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Bond Exchange Holdings Limited (ABE) ORDINARY FULLY PAID |
Financials |
$3 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:57AM |
$0.034 |
$0.020 |
fallen by
41.18%
|
|
ABE - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for the half-year ended 31 December 2025 was $1,397,081, up from $1,145,346 in the prior period.
- The company reported a loss after tax of $1,647,816 for the period, which was an improvement from a loss of $1,920,086 in the previous period.
- Total comprehensive loss for the period was $1,646,360.
- Net tangible assets per ordinary share decreased to $(0.043) from $(0.024) compared to the same period last year.
- The company did not declare any dividends during the reporting period.
- Total assets as of 31 December 2025 were $4,355,890, compared to $5,609,057 at 30 June 2025.
- Total liabilities increased to $6,825,616 from $6,432,423 as of 30 June 2025.
- The report includes a note on intangible assets, indicating software development costs and their amortization.
- The auditor's report highlighted a material uncertainty related to going concern, but with no modification to the auditor's conclusion regarding the financial statements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platina Resources Limited (PGM) ORDINARY FULLY PAID |
Materials |
$16 |
Mt McKenna Gold Project - Phase 2 drilling underway
|
27 Feb 2026 9:57AM |
$0.030 |
$0.025 |
fallen by
16.67%
|
|
PGM - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 2 aircore drilling underway at Mt McKenna Project.
- 10-day program over 4,500 meters at Target 2.
- Part of a planned 20,000-meter drilling campaign for 2026.
- Additional gravity and aeromagnetic surveys completed.
- Cultural heritage surveys completed for future drilling phases.
- Focus on expanding and refining geological targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$791 |
Update - Dividend/Distribution - VSL
|
27 Feb 2026 9:56AM |
$6.490 |
$5.400 |
fallen by
16.80%
|
|
| Yowie Group Ltd (YOW) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Dec 24 - Half Year Accounts
|
27 Feb 2026 9:56AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$15 |
Half Year Results Presentation
|
27 Feb 2026 9:56AM |
$0.099 |
$0.057 |
fallen by
42.42%
|
|
5GN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 36.5% to $36.2 million.
- EBITDA increased to $1.3 million, reflecting a 34.1% YoY growth.
- Gross profit margin improved to 52%.
- AUCyber Limited contributed $10.4 million in revenue.
- Cash balance decreased by $11.5 million due to growth initiatives.
- $4.2 million returned via on-market share buyback.
- Strategic review of AUCyber integration and potential full acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$20 |
Half Year Report & Accounts
|
27 Feb 2026 9:56AM |
$0.047 |
$0.041 |
fallen by
12.77%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- Half-year profit after tax was $1,466,049, marking a significant improvement from the previous year's loss.
- Sales revenue increased by 53% to $7,975,096, driven by clinical trial agreements and the integration of TrialsWest.
- The company's core business focuses on software-as-medical-device technologies for radiological image analysis.
- Research and development expenditure for the half-year was $601,617.
- No significant changes in the state of affairs occurred during the half-year.
- No dividends were declared for the current financial period.
- The financial report complies with Australian accounting standards and assumes going concern.
- The directors are confident in the company's ability to meet its debts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$57 |
Cleansing Statement - Section 708A(12C)(e)
|
27 Feb 2026 9:56AM |
$0.100 |
$0.080 |
fallen by
20%
|
|
| AUCyber Limited (CYB) ORDINARY FULLY PAID |
Information Technology |
$12 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:55AM |
$0.062 |
$0.058 |
fallen by
6.45%
|
|
CYB - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for the half-year was $9,256,714.
- Loss before tax was $2,422,416.
- Cash balance at the end of the period was $1,972,790.
- Total assets amounted to $12,082,446.
- Share capital remains at $135,840,073.
- Employee share options were issued as part of long-term incentives.
- Depreciation and amortization costs were significant.
- Equity totals $5,463,886.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Electro Optic Systems Holdings Limited (EOS) ORDINARY FULLY PAID |
Industrials |
$1,632 |
Notification of cessation of securities - EOS
|
27 Feb 2026 9:55AM |
$8.540 |
$8.460 |
fallen by
0.94%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$15 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:55AM |
$0.099 |
$0.057 |
fallen by
42.42%
|
|
5GN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $6.43 million compared to a profit of $6.33 million in the previous year.
- Revenue increased by 36.5% to $36.2 million.
- Strong demand for cybersecurity services with revenue contribution from AUCyber Limited.
- Employee benefits and cloud hosting costs increased significantly.
- Cash balance of $14 million at the end of the period.
- Completion of a share buyback program acquiring 30,095,039 shares for $4.2 million.
- No dividends declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$302 |
Update on Strategic Review
|
27 Feb 2026 9:55AM |
$1.255 |
$1.170 |
fallen by
6.77%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Wellnex Life Releases Half Year Report
|
27 Feb 2026 9:54AM |
$0.105 |
$0.079 |
fallen by
24.76%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 8% to $12.9 million.
- Gross margin improved by 9.4 percentage points to 32.1%.
- Achieved operating breakeven in Q2 FY26.
- Focus on leaner operations and tighter capital management.
- Exploring funding options for capital raising.
- Committed to delivering consistent performance in H2 FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$52 |
Imugene to Present at TD Cowen Annual Health Care Conference
|
27 Feb 2026 9:54AM |
$0.240 |
$0.145 |
fallen by
39.58%
|
|
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$144 |
Section 708A Notice - Share Issue
|
27 Feb 2026 9:54AM |
$0.465 |
$0.450 |
fallen by
3.23%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:54AM |
$0.105 |
$0.079 |
fallen by
24.76%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $1.793 million for the half-year ending 31 December 2025.
- Operating cash outflows totaled $3.142 million.
- Current liabilities exceeded current assets by $4.252 million.
- No dividends paid during the period.
- Total equity stood at $10.044 million.
- Significant borrowings and related party loans detailed.
- Auditor's review affirmed compliance with accounting standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austin Metals Limited (AYT) ORDINARY FULLY PAID |
Materials |
$8 |
Application for quotation of securities - AYT
|
27 Feb 2026 9:53AM |
$0.004 |
$0.004 |
fallen by
12.50%
|
|
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$144 |
Application for quotation of securities - FTI
|
27 Feb 2026 9:53AM |
$0.465 |
$0.450 |
fallen by
3.23%
|
|
| Maggie Beer Holdings Ltd (MBH) ORDINARY FULLY PAID |
Consumer Staple |
$36 |
1HFY26 Results Presentation
|
27 Feb 2026 9:53AM |
$0.081 |
$0.080 |
fallen by
1.23%
|
|
MBH - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit from operations increased by 68% to $398K.
- Maggie Beer Products sales increased by 4.6%, while Hampers & Gifts Australia sales declined by 4.8%.
- Operational savings of $2.2 million achieved through cost-out programs.
- Cash position improved by $11.5 million with no debt.
- Strategic goals include revenue growth to $100m+, new product development, and expansion of channels.
- Ongoing strategic review of Hampers & Gifts Australia with potential merger, alliance, or sale options.
- Operational improvements include platform transition to Shopify and inventory control enhancements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$33 |
Investor Presentation
|
27 Feb 2026 9:53AM |
$0.090 |
$0.068 |
fallen by
24.44%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,492 |
Appendix 4E and 2025 full year accounts
|
27 Feb 2026 9:53AM |
$13.440 |
$11.780 |
fallen by
12.35%
|
|
NEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax for 2025 was A$30.4 million, compared to A$142.0 million in 2024.
- Basic earnings per share for 2025 were A$0.2373.
- Total revenue for 2025 was A$84.8 million, a 63% decrease from 2024.
- Royalty income increased by 15% to A$64.6 million.
- Corporate and administrative costs for 2025 were A$6.2 million.
- Cash and short-term investments at the end of 2025 were A$296.1 million.
- The company executed a A$39.6 million share buy-back.
- Financial statements received an unqualified audit opinion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
